GRANULES INDIA
Quarterly Results Analysis [Mar2025]
GRANULES INDIA Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,197 Cr | ₹1,138 Cr | ₹967 Cr | ₹1,180 Cr | ₹1,176 Cr | ₹1,156 Cr | ₹1,189 Cr | ₹986 Cr |
Expenses | ₹945 Cr | ₹907 Cr | ₹763 Cr | ₹921 Cr | ₹920 Cr | ₹905 Cr | ₹977 Cr | ₹849 Cr |
Operating Income | ₹252 Cr | ₹230 Cr | ₹203 Cr | ₹259 Cr | ₹256 Cr | ₹250 Cr | ₹213 Cr | ₹137 Cr |
Other Income | ₹2 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr |
Interest | ₹24 Cr | ₹27 Cr | ₹26 Cr | ₹27 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr | ₹22 Cr |
Depreciation | ₹63 Cr | ₹57 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹52 Cr | ₹53 Cr | ₹49 Cr |
Profit Before Tax | ₹198 Cr | ₹153 Cr | ₹128 Cr | ₹181 Cr | ₹176 Cr | ₹170 Cr | ₹136 Cr | ₹65 Cr |
Profit After Tax | ₹152 Cr | ₹118 Cr | ₹97 Cr | ₹135 Cr | ₹130 Cr | ₹126 Cr | ₹102 Cr | ₹48 Cr |
EPS | ₹6.27 | ₹4.85 | ₹4.01 | ₹5.56 | ₹5.35 | ₹5.18 | ₹4.21 | ₹1.98 |
Industry Peers & Returns | 1W | 1M | 1Y |
GRANULES INDIA | -0.4% | -7.7% | -0.2% |
SUN PHARMACEUTICAL INDUSTRIES | -0% | -0.4% | 10.2% |
DIVIS LABORATORIES | 1.4% | 4.1% | 50.3% |
CIPLA | 0.5% | 1.6% | 1.4% |
TORRENT PHARMACEUTICALS | -1.2% | 7.1% | 18.3% |
DR REDDYS LABORATORIES | 1.7% | 1.2% | 1.5% |
MANKIND PHARMA | 5% | 3.3% | 11% |
ZYDUS LIFESCIENCES | 1.2% | 4.8% | -7% |
LUPIN | 2% | -0.9% | 19.8% |
GRANULES INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.25 % |
Y-o-Y | 1.84 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹1,197 Cr | 5.25 | |
Dec2024 | ₹1,138 Cr | 17.70 | |
Sep2024 | ₹967 Cr | -18.07 | |
Jun2024 | ₹1,180 Cr | 0.35 | |
Mar2024 | ₹1,176 Cr | 1.75 | |
Dec2023 | ₹1,156 Cr | -2.85 | |
Sep2023 | ₹1,189 Cr | 20.70 | |
Jun2023 | ₹986 Cr | - |
GRANULES INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9.58 % |
Y-o-Y | -1.31 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹252 Cr | 9.58 | |
Dec2024 | ₹230 Cr | 13.27 | |
Sep2024 | ₹203 Cr | -21.58 | |
Jun2024 | ₹259 Cr | 1.39 | |
Mar2024 | ₹256 Cr | 2.09 | |
Dec2023 | ₹250 Cr | 17.61 | |
Sep2023 | ₹213 Cr | 55.66 | |
Jun2023 | ₹137 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 4.10 % |
Y-o-Y | -3.13 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 21.07% | 4.10 | |
Dec2024 | 20.24% | -3.76 | |
Sep2024 | 21.03% | -4.28 | |
Jun2024 | 21.97% | 1.01 | |
Mar2024 | 21.75% | 0.32 | |
Dec2023 | 21.68% | 21.12 | |
Sep2023 | 17.9% | 28.96 | |
Jun2023 | 13.88% | - |
GRANULES INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 29.27 % |
Y-o-Y | 17.27 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹152 Cr | 29.27 | |
Dec2024 | ₹118 Cr | 20.95 | |
Sep2024 | ₹97 Cr | -27.79 | |
Jun2024 | ₹135 Cr | 3.86 | |
Mar2024 | ₹130 Cr | 3.18 | |
Dec2023 | ₹126 Cr | 23.05 | |
Sep2023 | ₹102 Cr | 113.21 | |
Jun2023 | ₹48 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 22.82 % |
Y-o-Y | 15.14 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 12.7 % | 22.82 | |
Dec2024 | 10.34 % | 2.78 | |
Sep2024 | 10.06 % | -11.83 | |
Jun2024 | 11.41 % | 3.45 | |
Mar2024 | 11.03 % | 1.47 | |
Dec2023 | 10.87 % | 26.69 | |
Sep2023 | 8.58 % | 76.54 | |
Jun2023 | 4.86 % | - |
GRANULES INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 29.28 % |
Y-o-Y | 17.20 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹6.27 | 29.28 | |
Dec2024 | ₹4.85 | 20.95 | |
Sep2024 | ₹4.01 | -27.88 | |
Jun2024 | ₹5.56 | 3.93 | |
Mar2024 | ₹5.35 | 3.28 | |
Dec2023 | ₹5.18 | 23.04 | |
Sep2023 | ₹4.21 | 112.63 | |
Jun2023 | ₹1.98 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD